
Johnson & Johnson
JNJ 234.34 (0.00%) 0.00
Health Care
Pharmaceuticals
Quality Checklist 6/8
5Y Shares Out Change < 0%
ROIC > 10%
Debt/Equity < 1
Current Ratio > 1
Net Margin > 10%
Est. EPS Growth > 5%
Quick Ratio > 1
Past Net Income CAGR > 0%
0.0%of Portfolio
My holdings
Day change:
Total change:
Shares:Cost basis:
Market cap: $564.11(B)
EV: $597.04(B)
Total Equity: $81.19(B)
Earnings date: Jul-14-2026
P/E: 26.81
Forward P/E: 20.24
P/FCF: 31.71
P/S: 5.86
P/B: 6.95
EPS: $8.7
EPS (fwd): $11.6
FCF/share: $7.4
Revenue/share: $40.0
Book value/share: $33.7
ROIC: 21.7%
ROA: 13.5%
ROE: 33.6%
Debt/Equity: 0.68
Current Ratio: 1.00
Gross margin: 68.0%
Operating margin: 26.2%
Net margin: 21.8%
Dividend/share: $5.2
Div. yield: 2.22%
Growth Estimates
Revenue
CAGR: 6.6%FY+1$100.88(B)
FY+2(+6.3%)$107.19(B)
FY+3(+7.0%)$114.70(B)
FY+4(+6.2%)$121.77(B)
FY+5(+7.0%)$130.30(B)
Net Income
CAGR: 9.7%FY+1$28.24(B)
FY+2(+9.5%)$30.92(B)
FY+3(+9.3%)$33.80(B)
FY+4(+9.1%)$36.88(B)
FY+5(+10.8%)$40.86(B)
EPS
CAGR: 10.1%FY+1$11.58
FY+2(+9.8%)$12.71
FY+3(+9.8%)$13.95
FY+4(+9.5%)$15.28
FY+5(+11.5%)$17.03
FCF per share
CAGR: 7.5%FY+1$11.15
FY+2(+11.9%)$12.48
FY+3(+5.1%)$13.11
FY+4(+6.3%)$13.94
FY+5(+6.9%)$14.90
